1.
Phase 3 Trial Demonstrates Superior Patient Treatment Convenience of MC2-01 Calcipotriene Plus Betamethasone Dipropionate Cream Compared to Current Topical Suspension. J of Skin [Internet]. 2020 Sep. 2 [cited 2026 May 7];4(5):s62. Available from: https://skin.dermsquared.com/skin/article/view/1011